Shogun Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 4.00 M
as on 09-12-2024
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.00 Cr
as on 09-12-2024
- Revenue 720.15%
(FY 2023)
- Profit -19.13%
(FY 2023)
- Ebitda 30.67%
(FY 2023)
- Net Worth -134.84%
(FY 2023)
- Total Assets 19.77%
(FY 2023)
About Shogun Lifesciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹10.00 Cr.
Surinder Chaudhary, Rajesh Jindal, Neeraj Jindal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24299DL2021PTC379521
- Company No.
379521
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shogun Lifesciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Jindal  | Director | 03-Apr-2021 | Current |
| Neeraj Jindal | Director | 16-Aug-2021 | Current |
| Surinder Chaudhary | Director | 16-Aug-2021 | Current |
| Rajesh Jindal | Director | 16-Aug-2021 | Current |
| Devendra Singh | Whole-Time Director | 01-Feb-2024 | Current |
Financial Performance and Corporate Structure Insights of Shogun Lifesciences.
Shogun Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 720.15% increase. The company also saw a substantial fall in profitability, with a 19.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 134.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shogun Lifesciences?
In 2023, Shogun Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Smith N Smith Chemicals LimitedActive 11 years 7 monthsSurinder Chaudhary, Rajesh Jindal and 2 more are mutual person
Safex Chemicals ( India) LimitedActive 33 years 11 monthsSurinder Chaudhary, Rajesh Jindal and 2 more are mutual person
Indo Swiss Chemicals LimitedActive 13 years 8 monthsSurinder Chaudhary, Rajesh Jindal and 2 more are mutual person
Agcare Technologies Private LimitedActive 2 years 10 monthsSurinder Chaudhary, Rajesh Jindal and 2 more are mutual person
Shogun Organics LimitedActive 31 years 3 monthsSurinder Chaudhary, Rajesh Jindal and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 09 Aug 2023 | ₹10.00 Cr | Open |
How Many Employees Work at Shogun Lifesciences?
Shogun Lifesciences has a workforce of 16 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shogun Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shogun Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
